Two Sigma Investments
AMPE

Two Sigma Investments’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Two Sigma Investments’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-661
Closed -$12K – 3234
2022
Q3 		$12K Buy
661
+445
+206% +$15.6K ﹤0.01% 2411
2022
Q2 		$11K Buy
+216
New +$16.1K ﹤0.01% 2432

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Two Sigma Investments's AMPE Position: Q4 2022 in Review

Two Sigma Investments sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 661 shares — an estimated $12K sold.

Two Sigma Investments first reported a position in AMPE in Q2 2022 and held it in 2 quarters. The position peaked at $12K in Q3 2022. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Two Sigma Investments reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 661 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $12K.
  • Two Sigma Investments first reported a position in Ampio Pharmaceuticals Inc. in Q2 2022 and held it in 2 quarters.
  • Two Sigma Investments's Ampio Pharmaceuticals Inc. position peaked at $12K in Q3 2022.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.